Transform obesity and type 2 diabetes management with Semaglutide, a groundbreaking GLP-1 receptor agonist delivering remarkable weight loss and metabolic benefits backed by robust FDA-approved research.
Mechanism
Semaglutide stimulates GLP-1 receptors, boosting insulin secretion and suppressing glucagon while slowing gastric emptying. This powerful combination enhances blood sugar control and curbs appetite, acting through dual pathways in the pancreas and brain.
Research
Semaglutide's effectiveness is underscored by the STEP trials, showcasing an impressive 14.9-17.4% average weight loss, alongside the SELECT trial revealing a 20% decrease in major adverse cardiovascular events. Its safety and efficacy were validated in extensive Phase III clinical trials, leading to FDA approvals across multiple indications.
Synergies
Maximize results by combining semaglutide with lifestyle changes and other treatments. Ben IQ will analyze YOUR labs and goals to find the perfect combination for you.
Trade-Offs
While semaglutide boasts impressive results, potential gastrointestinal side effects and careful titration should be considered. Individualized data is crucial for your unique circumstance.